Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

“Non-Controversial” E-Prescribing Standards May Be Ready Before Deadline

Executive Summary

The National Committee on Vital & Health Statistics is likely to apply some of the technology standards developed for electronic billing practices under the Health Insurance Portability & Accountability Act to the drafting of e-prescribing standards under Medicare

You may also be interested in...



E-Prescribing Committee Endorses NCPDP Standard For Rx Transmissions

The National Council for Prescription Drug Programs SCRIPT standard and its code sets should be used for electronic communication of prescription information between prescribers and pharmacies, the National Committee on Vital and Health Statistics Subcommittee on Standards and Security said

E-Prescribing Committee Endorses NCPDP Standard For Rx Transmissions

The National Council for Prescription Drug Programs SCRIPT standard and its code sets should be used for electronic communication of prescription information between prescribers and pharmacies, the National Committee on Vital and Health Statistics Subcommittee on Standards and Security said

Pfizer Weighs In On E-Prescribing: Pricing Granularity Critical

The level of drug pricing granularity available to health care providers via electronic prescribing systems is one key issue to be resolved in setting standards for e-prescribing under Medicare

Related Content

UsernamePublicRestriction

Register

PS044074

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel